CVE-2020-12023: Philips IntelliBridge Enterprise (IBE) · Sensitive Data in Logs
Affects Philips IntelliBridge Enterprise (IBE)Source CVE Database V5
Not known to be exploited · CVSS 2.0 Low.
Data as of 26 Oct 2026, 08:30 UTC
- EPSS
- 0.5% chance of exploitation in 30 days – higher than 43% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:A/AC:H/PR:H/UI:N/S:U/C:L/I:N/A:NExploitation evidence
Disclosed: evidence found.
CVE published 11 Jun 2020
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Philips IntelliBridge Enterprise (IBE) | Affected
| Fixed in– |
AI-suggested
1. Restrict administrative access strictly using role-based access controls and multi-factor authentication to minimize the risk of unauthorized log access. 2. Implement encryption or masking of sensitive data such as user credentials before logging to prevent plaintext exposure. 3. Regularly audit and monitor access to transaction logs and administrative portals for anomalous activities. 4. Apply network segmentation to isolate IntelliBridge Enterprise systems and connected medical devices from broader enterprise networks, reducing attack surface. 5. Engage with Philips support or security advisories to obtain any available patches or updates addressing this vulnerability. 6. If patching is not immediately available, consider disabling or limiting logging of sensitive authentication payloads where feasible. 7. Conduct staff training on secure credential management and incident response procedures specific to medical device integrations. 8. Maintain comprehensive incident detection and response capabilities to quickly identify and remediate potential misuse of exposed credentials.
Description
Philips IntelliBridge Enterprise (IBE), Versions B.12 and prior, IntelliBridge Enterprise system integration with SureSigns (VS4), EarlyVue (VS30) and IntelliVue Guardian (IGS). Unencrypted user credentials received in the IntelliBridge Enterprise (IBE) are logged within the transaction logs, which are secured behind the login based administrative web portal. The unencrypted user credentials sent from the affected products listed above, for the purpose of handshake or authentication with the Enterprise Systems, are logged as the payload in IntelliBridge Enterprise (IBE) within the transaction logs. An attacker with administrative privileges could exploit this vulnerability to read plain text credentials from log files.